ARIMIDEX
ARIMIDEX
Approved
DIN Number
02224135
Drug Class
Human
Market Date
Aug 30, 1996
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02224135
AIG Number0128681001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BG03 ANASTROZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ANASTROZOLEActive
Strength: 1 MG
Monograph: ANASTROZOLE